Cell and Gene Therapy 25/06/2019 Technology Review: Gene Editing Edition one of Phacilitate’s technology review series examines gene editing approaches by viral and non-viral methods and where to access these services
Cell and Gene Therapy 23/06/2019 Patient Access and Delivery of Advanced Therapies - Part Two An interview with Dr Matthew Frigault, Instructor and Clinical Assistant in Medicine, Massachusetts General Hospital
Cell and Gene Therapy 30/05/2019 ASGCT 2019: Patients are Top Priority Amanda Kendall, Phacilitate's Head of Community, gives her account of ASGCT 2019
Cell and Gene Therapy 28/05/2019 Are We Ready for a $5m Gene Therapy? Episode two of the Phacilitate Leaders World super plenary sessions with Dave Lennon, President of AveXis, Inc
Cell and Gene Therapy 28/05/2019 Advanced Therapies: Cost-effective but Unaffordable? Episode three of the Phacilitate Leaders World super plenary sessions with Michael Meyers, Head of Investment Banking...
Cell and Gene Therapy 24/05/2019 Uncovering Innovation: Phacilitate’s Trip to Israel Phacilitate's Jeremy Roden and David Green ventured out to Tel Aviv to lift the lid on the biotech and advanced therapies...
Cell and Gene Therapy 22/05/2019 Manufacturing Advanced Therapies in Europe A comprehensive guide to Europe's growing advanced therapies and viral vector manufacturing landscape
Cell and Gene Therapy 20/05/2019 Five Take-aways from the Advanced Therapies Network Investment Event Phacilitate's Kim Barnes gives her account of the Advanced Therapies Network investment meeting in London
Cell and Gene Therapy 13/05/2019 60 seconds with...Jeff Robertson, Charter Medical Charter Medical's President on automation and tubing standardisation
Cell and Gene Therapy 08/05/2019 Patient Access and Delivery of Advanced Therapies - Part One An interview with Jacqueline Barry, Chief Clinical Officer at Cell and Gene Therapy Catapult
Cell and Gene Therapy 07/05/2019 60 seconds with...Philip Wills, Paragon Bioservices Paragon Bioservice's Chief Commercial Officer on being acquired by Catalent
Cell and Gene Therapy 01/05/2019 [WEBINAR] Standardization and Large-scale Manufacturing of Helper... Learn more about the background of helper plasmids, their application, regulatory considerations and advantages. Hosted by Aldevron.
Cell and Gene Therapy 23/04/2019 The Patient’s Eye View of the Kymriah® Story Episode one of the Phacilitate Leaders World super plenary sessions, led by Anthony Davies, Dark Horse Consulting
Cell and Gene Therapy 16/04/2019 Keeping up with the pace of technology in an evolving field of... Alberto Santagostino, Lonza Pharma & Biotech's SVP Cell and Gene Technologies delivers a keynote presentation at Phacilitate Leaders World 2019...
Cell and Gene Therapy 29/03/2019 [VIDEO] Join the Advanced Therapies Revolution The story of advanced therapies and its monumental success stories told by industry leaders
